Stockscreener 앱 받기
95.17
0.01%
0.01
시간 외 거래:
95.17
Incyte Corp 주식(INCY)의 최신 뉴스
Incyte releases data that shows promise in treating rare blood disease - Delaware Business Now
Sun Pharma Claims New Pill Distinct From Incyte's Hit Drug - Law360
Incyte Presents Updated Positive Data at ASH 2025 Reinforcing the Potential of INCA033989, its First-in-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Essential Thrombocythemia - BioSpace
Incyte stock holds Market Perform rating at Citizens on CALR therapy lead - Investing.com
Is Incyte Still Attractive After Its Strong 2025 Rally and DCF Valuation Gap? - Yahoo Finance
Is Incyte (INCY) Quietly Reframing Its R&D Story With Breakthrough Status And Legal Firepower? - Yahoo Finance
Incyte (INCY) Reports Promising Phase 1 Results for INCA033989 i - GuruFocus
Incyte’s experimental drug shows strong response in blood disorder By Investing.com - Investing.com Canada
Incyte’s experimental drug shows strong response in blood disorder - Investing.com
Incyte presents data showing 90% response rate for blood cancer drug - StreetInsider
Incyte Corp. stock outperforms competitors despite losses on the day - MarketWatch
Institution Moves: Why Incyte Corporation ICY stock stays undervaluedWatch List & Short-Term Trading Alerts - BỘ NỘI VỤ
Incyte (NASDAQ:INCY) Trading Down 6.6%Should You Sell? - MarketBeat
Incyte (INCY) Maintained as Equal-Weight by Morgan Stanley with Raised Price Target | INCY Stock News - GuruFocus
Incyte gains FDA Breakthrough designation for its candidate against essential thrombocythemia - marketscreener.com
INCY: Wells Fargo Raises Price Target to $116 | INCY Stock News - GuruFocus
Incyte's Rare Blood Cancer Therapy Gets FDA's Breakthrough Status - Yahoo Finance
Incyte (INCY) Stock Receives Upgraded Rating and Price Target from Mizuho | INCY Stock News - GuruFocus
What's Going On With Incyte Stock Monday?Incyte (NASDAQ:INCY) - Benzinga
Leerink Partners Adjusts Incyte Price Target to $128 From $103, Maintains Outperform Rating - marketscreener.com
Incyte stock price target raised to $128 by Leerink on mCALR data - Investing.com
Incyte Corporation $INCY Shares Purchased by American Century Companies Inc. - MarketBeat
Incyte Says Rare Blood Cancer Therapy Receives FDA Breakthrough Designation - marketscreener.com
Incyte Names Veteran Biopharma Attorney as New General Counsel - MyChesCo
Wells Fargo Adjusts Price Target on Incyte to $116 From $97, Maintains Overweight Rating - marketscreener.com
Mizuho upgrades Incyte stock rating to Outperform on promising ASH data - Investing.com
Incyte stock price target raised by BofA to $118 on promising blood disorder data - Investing.com
Mizuho Upgrades Incyte to Outperform From Neutral, Adjusts Price Target to $121 From $90 - marketscreener.com
First Trust Advisors LP Sells 12,101 Shares of Incyte Corporation $INCY - MarketBeat
Transcript : Incyte CorporationSpecial Call - marketscreener.com
Incyte (INCY) Secures FDA Breakthrough Therapy Designation for I - GuruFocus
Incyte (INCY) Reveals Promising Phase 1 Results for INCA033989 i - GuruFocus
Incyte (INCY) Receives FDA Breakthrough Therapy Designation for INCA033989 - GuruFocus
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025 - Yahoo Finance
18,946 Shares in Incyte Corporation $INCY Bought by 1832 Asset Management L.P. - MarketBeat
Incyte: Buy At This Inflection Point (NASDAQ:INCY) - Seeking Alpha
Lido Advisors LLC Buys Shares of 13,529 Incyte Corporation $INCY - MarketBeat
Marshall Wace LLP Takes Position in Incyte Corporation $INCY - MarketBeat
Incyte Corporation $INCY Shares Bought by Fisher Asset Management LLC - MarketBeat
Dodge & Cox Sells 269,147 Shares of Incyte Corporation $INCY - MarketBeat
Insider Selling: Incyte (NASDAQ:INCY) EVP Sells 20,105 Shares of Stock - MarketBeat
Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)December 3, 2025 - BioSpace
Incyte Corporation (NASDAQ:INCY) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
VP Stein Sells 22,664 ($2.3M) Of Incyte Corp [INCY] - TradingView
Global Vitiligo Foundation Applauds Partnership Between Incyte and Winnie Harlow to Elevate Awareness and Understanding of Vitiligo - Yahoo Finance
Myeloproliferative Disorder Treatment Market Size Report 2032 - openPR.com
Mackenzie Financial Corp Has $24.67 Million Stock Position in Incyte Corporation $INCY - MarketBeat
Korea Investment CORP Decreases Stake in Incyte Corporation $INCY - MarketBeat
Incyte and Winnie Harlow Join Forces to Share Her Personal Vitiligo Story and Spark Conversation and Understanding - Business Wire
Incyte Appoints Richard Hoffman as Executive Vice President and General Counsel - BioSpace
Hsbc Holdings PLC Cuts Position in Incyte Corporation $INCY - MarketBeat
Incyte (INCY): Evaluating Valuation Following Recent Share Price Momentum - Yahoo Finance
Incyte Corp. stock underperforms Monday when compared to competitors - MarketWatch
Incyte Sets December Investor Lineup as Pipeline Progress Draws Market Attention - MSN
Incyte appoints Richard Hoffman as executive VP and general counsel By Investing.com - Investing.com Nigeria
Incyte appoints Richard Hoffman as executive VP and general counsel - Investing.com
CACS Drug Market Accelerates at 3.9% CAGR to 2033, Reaching USD - openPR.com
Incyte Corporation $INCY Shares Purchased by Russell Investments Group Ltd. - MarketBeat
Grantham Mayo Van Otterloo & Co. LLC Decreases Position in Incyte Corporation $INCY - MarketBeat
Incyte Corp. stock underperforms Friday when compared to competitors - MarketWatch
Vinva Investment Management Ltd Buys 92,379 Shares of Incyte Corporation $INCY - MarketBeat
Incyte Corporation $INCY Shares Sold by Franklin Resources Inc. - MarketBeat
Incyte (INCY) Up 17.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Incyte Corporation $INCY Shares Purchased by North Star Asset Management Inc. - MarketBeat
Incyte: This Profitable Biotech Trades Like A Melting Iceberg (NASDAQ:INCY) - Seeking Alpha
Swiss National Bank Has $33.91 Million Holdings in Incyte Corporation $INCY - MarketBeat
Incyte: Riding Jakafi, Bracing For Generic Headwinds (NASDAQ:INCY) - Seeking Alpha
Legal & General Group Plc Has $106.67 Million Position in Incyte Corporation $INCY - MarketBeat
Incyte’s principal accounting officer Tray Thomas sells $79k in stock - Investing.com
Incyte Corp's Principal Accounting Officer Sells Shares - TradingView
1.00%
0.12%
자본화:
|
볼륨(24시간):